期刊文献+

急性淋巴细胞白血病患儿诱导治疗后发生可逆性后部脑病综合征的临床及影像学特点 被引量:4

Clinical and imaging characteristics of posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia after chemotherapy induction
原文传递
导出
摘要 目的 探讨急性淋巴细胞性白血病(ALL)患儿在诱导化疗期间发生可逆性后部脑病综合征(PRES)的临床特征、MRI特点及其可能的发病机制.方法 根据中华医学会儿科学分会制定的标准进行ALL的诊断与治疗,共有11例ALL患儿在诱导化疗后出现PRES.对这11例患儿的临床表现、影像学特点、预后进行研究并随访1年.患儿均在首次影像学检查后1、3、6、12个月时随访检查.结果 临床表现主要为头痛(10/11例)、癫(痫)发作(7/11例)、高血压(4/11例)、视力障碍(6/11例)、意识障碍(5/11例)和走路不稳(2/11例).颅脑MRI显示病灶分布于枕叶(9/11例)、顶叶(8/11例)、额叶(5/11例)、颞叶(3/11例)、侧脑室周围及半卵圆中心深部白质(2/11例)、小脑半球(1/11例)等不同部位,具有多灶性、对称性、后部分布为主的特点.PRES发生后立即停用化疗药物及对症处理,大多数病例临床症状及影像学病灶逐渐消失.随访1年,9例预后良好,无后遗症;1例遗留症状性癫(痫)(颅脑MRI示左侧颞叶病灶),1例遗留轻度视力障碍.各病例临床症状和颅脑MRI病灶消失后继续化疗,未见再次PRES发生.结论 虽然PRES临床与影像学特征具有多样性,但当神经系统症状出现时,PRES可能是ALL化疗期间重要并发症.PRES早期诊断与治疗具有可逆性,因此应该重视PRES的发生,使ALL得到更好的治疗. Objective To investigate the clinical features, brain imaging significance and the possible pathogenesis of posterior reversible encephalopathy syndrome (PRES) in childhood acute lymphoblastic leukemia (ALL) followed by chemotherapy induction.Methods The diagnosis and treatment of ALL were performed according to the guidelines of the Pediatric Association of Chinese Medical Association.There were 11 cases of pediatric ALL who developed PRES after chemotherapy induction.The clinical presentations, initial and follow-up radiologic features, and the neurologic outcomes of these 11 cases were investigated for one-year follow-up.All patients were reexamined 1,3,6, and 12 months after first imaging.Results Headache (10/1 1 cases), epileptic seizure (7/11 cases), high blood pressure (4/11 cases) ,visual impairment (6/11 cases) ,disturbance of consciousness (5/11 cases) and walking instability (2/11 cases) were the most common symptoms of these ALL patients with PRES.Magnetic resonance imaging (MRI) scanning revealed that lesions were mainly distributed in occipital lobe (9/11 cases), parietal lobe (8/11 cases), frontal lobe (5/11 cases) ,temporal lobe (3/11 cases), the deep white matter of bilateral periventricular and centrum semiovale (2/11 cases) and hemisphaerium cerebelli (1/11 cases).The radiological findings indicated that lesions had multifocal,symmetrical and posteriorly distributed characteristics in the cerebral hemispheres.After the diagnosis of PRES,patients stopped chemotherapy courses promptly and received symptomatic treatment, and then the clinical and imaging symptoms of most cases gradually disappeared.After 1-year follow-up,9 patients had good prognosis and no sequelae, 1 patient had symptomatic epilepsy (brain magnetic resonance imaging scan showed lesions in the left temporal lobe) ,and 1 patient had slight visual impairment.After the craniocerebral symptoms disappeared clinically ALL chemotherapy continued in all patients and no recurrent PRES was observed.Conclusions Although the clinical and imaging features of PRES may be diverse ,PRES should be recognized as a possible important complication of ALL when neurological symptoms appear.However, PRES is reversible when the patients are diagnosed and treated at an early stage.Thus,the occurrence of PRES should be considered and investigated to optimize the early induction schemes for ALL treatment.
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2015年第24期1863-1867,共5页 Chinese Journal of Applied Clinical Pediatrics
关键词 可逆性后部脑病综合征 磁共振成像 诱导化疗 急性淋巴细胞性白血病 儿童 Posterior reversible encephalopathy syndrome Magnetic resonance imaging Chemotherapy induction Acute lymphoblastic leukemia Child
  • 相关文献

参考文献19

  • 1Guler T,Cakmak OY,Toprak SK,et al.Inlrathecal methotrexate-induced posterior reversible encephalopathy syndrome(PRES)[J].Turk J Haematol,2014,31(1):109-110.
  • 2Apuri S,Carlin K,Bass E,et al.Tacrolimus associated posterior reversi- ble encephalopathy syndrome-a case series and review[J].Mediterr J Hematol Infect Dis,2014,6(1):e2014014.
  • 3Belaramani KM,Lai V,Li CH,et al.Reversible posterior leukoencepha- lopathy syndrome in Chinese children induced by chemotherapy:a re- view of five cases[J].Hong Kong Med J,2011,17(1):61-66.
  • 4Tsukamoto S,Takeuchi M,Kawajiri C,et al.Posterior reversible ence- phalopathy syndrome in an adult patient with acute lymphoblastic leuke- mia after remission induction chemotherapy[J].Int J Hematol,2012,95(2):204-208.
  • 5Watsky MA,Carbone LD,An Q,et al.Bone turnover in long-term survi- vors of childhood acute lymphoblastic leukemia[J].Pediatr Blood Cancer,2014,61(8):1451-1456.
  • 6Kembhavi SA,Somvanshi S,Banavali S,et al.Pictorial essay:acute neu- rological complications in children with acute lymphoblastic leukemia[J].Indian J Radiol Imaging,2012,22(2):98-105.
  • 7周芬,金润铭,邱奕宁,徐云云,夏忆.前B急性淋巴细胞白血病细胞Sup-B15对化疗药物敏感性及侵袭力的研究[J].中华实用儿科临床杂志,2014,29(3):186-189. 被引量:1
  • 8Kim SJ,Im SA,Lee JW,et al.Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia[J].Pediatr Neurol,2012,47(6):436-442.
  • 9Graham BR,Pylypchuk GB.Posterior reversible encephalopathy syn- drome in an adult patient undergoing peritoneal dialysis:a case report and literature review[J].BMC Nephrol,2014,15(1):10.
  • 10Subspecialty Group of Hematology Diseases.The society of pediatrics, Chinese medical association;editorial board,Chinese journal of pediat- rics.Recommendations for diagnosis and treatment of acute lympho- blastic leukemia in childhood(3rd revised version)[J].Zhonghua Er Ke Za Zhi,2006,44(5):392-395.

二级参考文献16

  • 1赵斌,葛金芳,朱娟娟,黄晓晖,李俊.小议在MTT法测细胞增殖抑制率中IC_(50)的计算方法[J].安徽医药,2007,11(9):834-836. 被引量:165
  • 2Mullighan CG,Su X,Zhang J. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia[J].New England Journal of Medicine,2009,(05):470-480.
  • 3Mullighan CG,Miller CB,Phillips LA. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros[J].NATURE,2008,(7191):110-114.
  • 4Tonnelle C,Imbert MC,Sainty D. Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen[J].The Hematology Journal,2003,(02):104-109.
  • 5Ezzat S,Zhu X,Loeper S. Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells[J].Molecular Endocrinology,2006,(11):2976-2986.
  • 6Iacobucci I,Lonetti A,Messa F. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors:implications for a new mechanism of resistance[J].Blood,2008,(09):3847-3855.
  • 7Meleshko AN,Movchan LV,Belevtsev MV. Relative expression of different Ikaros isoforms in childhood acute leukemia[J].Blood Cells, Molecules and Diseases,2008,(03):278-283.
  • 8Iacobucci I,Lonetti A,Cilloni D. Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method[J].HAEMATOLOGICA,2008,(12):1814-1821.
  • 9Koipally J,Georgopoulos K. Molecular dissection of the repression circuitry of Ikaros[J].Journal of Biological Chemistry,2002,(31):27697-27705.
  • 10Li X,Liu J,Zhou R. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation[J].British Journal of Haematology,2010.69-79.

同被引文献17

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部